Core Viewpoint - The China Securities Hong Kong 100 Pharmaceutical and Health Index has shown significant growth, with a 22.21% increase over the past month, 41.09% over the past three months, and a remarkable 96.31% year-to-date [1]. Group 1: Index Performance - The China Securities Hong Kong 100 Pharmaceutical and Health Index is currently at 1134.87 points [1]. - The index is classified based on the China Securities Industry Classification Standard, with a base date of December 31, 2004, set at 1000.0 points [1]. Group 2: Market Composition - The index is fully composed of stocks listed on the Hong Kong Stock Exchange, with a 100.00% allocation [1]. - The industry composition of the index includes: - Chemical drugs: 54.47% - Biological drugs: 19.42% - Pharmaceutical and biotechnology services: 14.91% - Medical commerce and services: 11.20% [1]. Group 3: Index Adjustment Mechanism - The index samples are adjusted biannually, specifically on the next trading day following the second Friday of June and December [2]. - Weight factors are generally fixed until the next scheduled adjustment, with provisions for temporary adjustments under special circumstances [2].
中证香港100医药卫生指数报1134.87点，前十大权重包含药明生物等